NFKB2 and nonpapillary renal cell carcinoma: Consistent with previous reports that determined elevated NF‐κB activity in ccRCC [69], we confirmed significantly upregulated expression of three members of the NF‐κB transcription factor family (NF‐κB2, RelA, and RelB) in our ccRCC cohort (Fig. S4A).